Virios Therapeutics Inc

NASDAQ:VIRI  
5.02
+0.07 (+1.41%)
Earnings Announcements

Virios Therapeutics Announces Third Quarter 2021 Financial Results

Published: 11/11/2021 12:20 GMT
Virios Therapeutics Inc (VIRI) - Virios Therapeutics Announces Third Quarter 2021 Financial Results and Provides Corporate Update.
Q3 Loss per Share $0.49.
Believes It Will Have Sufficient Resources to Fund Planned Operations Into Q1 2023.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.83

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.